Crema, Italy

Alberto Bologna



Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 33(Granted Patents)


Location History:

  • Vidigulfo, IT (2010)
  • Crema, IT (2007 - 2012)

Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Alberto Bologna: Pioneering Innovations in Pharmaceutical Synthesis

Introduction

Alberto Bologna, a prominent inventor based in Crema, Italy, has contributed significantly to the field of chemistry, particularly in pharmaceutical synthesis. With a total of eight patents to his name, Bologna's work continues to influence both academia and the pharmaceutical industry.

Latest Patents

Among his latest patents, Bologna has developed innovative intermediates for the preparation of pramipexole. This invention outlines intermediates useful for the synthesis of the drug and explores their applications in such synthesis. Additionally, he holds a patent for a process that facilitates the preparation of pyridine-methylsulfinyl compounds, detailing a method to produce a compound of a specific formula, as well as its salt forms.

Career Highlights

Alberto Bologna has made substantial contributions during his tenure at notable companies, including Dipharma S.p.a. and Dipharma Francis S.r.l. His role in these organizations has been pivotal in advancing research and development in the field of pharmaceuticals.

Collaborations

Throughout his career, Bologna has collaborated with esteemed professionals, including Gabriele Razzetti and Pietro Allegrini. These partnerships have fostered the development of innovative solutions and have broadened the scope of research initiatives.

Conclusion

In summary, Alberto Bologna's impressive portfolio of patents and his collaborative spirit highlight his dedication to innovation in pharmaceutical synthesis. His contributions not only reflect his expertise but also pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…